The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...

Journal in the field and provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications. Recent clinical trials utilizing high doses of adeno ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

In a recent study posted to the bioRxiv* pre-print server, researchers investigated the complement component 1q (C1q) binding and subsequent complement activation by neutralizing antibodies (nAbs) ...

The results of a newly reported study may offer scientists a strategy for mitigating the negative side effects associated with intravenous injection of nanoparticles used in medicine. The new approach ...

On October 5 th, 2023, the study appeared in Nature Nanotechnology. Nanotechnology’s main advantage over conventional medical treatments is its ability to more precisely target tissues, such as cancer ...

Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...

Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...